Healthbeat - Your Source for Daily Health Trends and Medical News

STAT+: DeepMind launches AlphaGenome, aiming to predict gene regulation from DNA sequence

Google's DeepMind launches AlphaGenome, an artificial intelligence model that predicts gene expression from DNA sequence.

STAT+: Pharmalittle: We’re reading about FDA probing deaths after Sarepta treatment, a Regeneron plan for charities, and more

The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene therapy

FDA Probes Gene Therapy After Two Deaths

(MedPage Today) -- The FDA is investigating the deaths of two boys with Duchenne muscular dystrophy who died soon after being treated with delandistrogene moxeparvovec (Elevidys) gene therapy, the ag

Jay Bhattacharya says he and Francis Collins ‘forgave each other’ after Covid clash

And more health news stories of the day.

CDC's Autism-Thimerosal Report; Teen Idol Bobby Sherman Dies; Best Place for Herpes?

(MedPage Today) -- Note that some links may require registration or subscription.

Dr Lal PathLabs adds Illumina’s NovaSeq X to its genomics division

The NovaSeq X system, featuring Illumina’s XLEAP-SBS chemistry, can generate more than 20,000 whole genomes per year, more than double the throughput of Illumina’s previous sequencers

Quadria Group appoints Rahul Agarwal as Partner at HealthQuad

Quadria Group intends to announce a few more senior appointments to strengthen the investment and the operating capability at HealthQuad

C.D.C. Vaccine Meeting: What to Watch For

Hints of a more skeptical approach to immunizations have already surfaced.

Kennedy’s Handpicked Vaccine Advisers Are Set to Meet for the First Time

The panelists will review measles vaccine recommendations and discuss a preservative that the health secretary has falsely claimed causes autism.

Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.

All News